Our company understands that technology and medicine in the pharmaceutical industry is constantly changing. Our team of experienced professionals stay current about the latest drug trends, regulations and market access.
We have 20 years of experience in management and development of clinical trials, submissions to agencies and strategic planning pre and post product launch. Our expertise lies in drugs, biologics, vaccines, devices, blood/cell products and nutraceuticals, across a wide range of therapeutic areas in Canada, US, Europe and the Middle East.
For more information and to discuss the specifics of your program, product development, clinical trial and regulatory needs please contact us at 1-647-205-9706.
Our team is continually keeping up with the changing clinical research trends and technology. We strive to find the most efficient ways to conduct and manage clinical trials (Phases I-IV) both internally and at a site level.
Our team will be your partner in making safe and effective healthcare products available in Canada, by providing exceptional service in defining Health Canada requirements, preparation of submissions (CTA and NDS), for a wide range of products, including: pharmaceuticals, biologics, blood and cell products, medical devices, nutritional products, supplements and cosmetics.
We partner with your commercial team in providing scientific and clinical support for pre and post launch stage. This includes managing key thought leader relationships, working with data and publishing reports from clinical trials, working on research initiatives outside of labelled indications, presenting educational information, providing product safety information for healthcare professionals (e.g., physicians, pharmacists, nurses) and to patients.
In addition we can work with business units in management of phase 4 trials, design and development of registries, conduct of pharmacoeconomic trials and assistance of investigators in conduction of investigator initiated trials from inception to publication.
Our Commitment to Innovation & Research Excellence is an Investment in the Future.